【受診を希望する患者さんはこちら】

岩田 大樹 Daiju Iwata     







 学会活動 

資格
日本眼科学会認定専門医
博士(医学)

所属学会
日本眼科学会(専門医)
日本眼炎症学会
アメリカ視覚眼科学研究会議
/ARVO
日本免疫学会

 経歴 

1996年 札幌北高等学校 卒業
2002年 北海道大学医学部 卒業
2002年 北海道大学医学部附属病院 研修医
2004年 北海道大学病院 眼科 医員
2005年 帯広協会病院眼科 医師
2010年 北海道大学大学院医学研究科博士課程修了
2011年 University College London Institute
      Of Ophthalmology(ポスドク研究員)
2014年 北海道大学病院 助教



 受賞歴 



2010年 高桑榮松奨学基金奨励賞
    (北海道大学大学院医学研究科)
2014年 文部科学省科学研究費補助金 
     研究活動スタート支援 【H24-25年】
2014年 財団法人日本応用酵素協会 平成26年度助成金
2016年 文部科学省科学研究費補助金 若手研究(B)
    【H28-30年】 (代表)
2016年 2016年度日本眼炎症学会 学術奨励賞






 業績 

  1. Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, Ishida S. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids. PLoS One. 2017; 12: e0172612
  2. Tagawa Y, Namba K, Mizuuchi K, Takemoto Y, Iwata D, Uno T, Fukuhara T, Hirooka K, Kitaichi N, Ohno S, Ishida S. Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. in press
  3. Tagawa Y, Namba K, Nakazono Y, Iwata D, Ishida S. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis. Allergol Int. 2017; 66: 338-343
  4. Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, Iwata D, Mizuki N, Ota M, Inoko H, Ishida S, Ohno S, Kitaichi N. HLA-B*51 carrier is susceptible to ocular symptoms of Behcet’s disease and its association becomes stronger towards east along Silk Road - a literature survey. Ocul Immunol Inflamm. 2017; 25: 37-40
  5. Iwata D, Mizuuchi K, Aoki K, Horie Y, Kase S, Namba K, Ohno S, Ishida S, Kitaichi N. Serial frequencies and clinical features of uveitis in Hokkaido, Japan. Ocul Immunol Inflamm. 2016; 20: 1-4
  6. Takemoto Y,Namba K, Uno T, Mizuuchi K, Iwata D, Ohno S, Hirooka K, Hashimoto Y, Saito W, Sugiyama K, Ishida S. Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy. Acta Ophthalmol. 2016; 94: e629-e636
  7. Regula JT, Lundh von Leithner P, Foxton R, Barathi VA, Cheung CM, Wey YS, Iwata D, Dostalek M, Moelleken J, Stubenrauch KG, Nogoceke E, Widmer G, Strassburger P, Koss MJ, Klein C, Shima DT, Hartmann G.Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases. EMBO Mol Med. 2016; 8: 1265-1288
  8. Satoh M, Namba K, Kitaichi N, Endo N, Kitamei H, Iwata D, Ohno S, Ishida S, Onoe K, Watarai H, Taniguchi M, Ishibashi T, Stein-Streilein J, Sonoda K, Kaer L V, Iwabuchi K. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis.Exp Eye Res. 2016; 153: 79-89
  9. Kase S, Namba K, Iwata D, Mizuuchi K, Kitaichi N, Tagawa Y, Okada-Kanno H, Matsuno Y, Ishida S. Diagnostic efficacy of cell block method for vitreoretinal lymphoma. Diagn Pathol. 2016; 11: 29
  10. Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, Ishida S. Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids. BMC Ophthalmol. 2015; 15: 181
  11. Dong Z, Iwata D, Kitaichi N, Takeuchi M, Sato M, Endo N, Iwabuchi K, Ando R, Fukuhara J, Kinoshita S, Lennikov A, Kitamura M, Mizuuchi K, Kanda A, Noda K, Namba K, Yamagishi S, Ohno S, Ishida S. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde derived-advanced glycation end product formation. J Leukoc Biol. 2014; 96: 1077-1085
  12. Rupesh Agrawal, Jayant Iyer, John Connolly, Iwata D, Stephen Teoh: Cytokines and Biologics in non-infectious autoimmune uveitis: Bench to Bedside 62: 74-81, 2014.
  13. Kase S, Namba K, Kitaichi N, Iwata D, Ohno S, Ishida S: Clinical features of human T lymphotropic virus type 1-associated uveitis in Hokkaido, Japan. Jpn J Ophthalmol 57: 379-384, 2013.
  14. Jin XH, Namba K, Saito W, Iwata D, Ishida S: Bacterial endophthalmitis caused by an intraocular cilium in a patient under treatment with infliximab. J Ophthalmic Inflamm Infect 5; 3: 50, 2013.
  15. Iwata D, Namba K, Mizuuchi K, Kitaichi N, Kase S, Takemoto Y, Ohno S, Ishida S: Correlation between elevation of serum antinuclear antibody titer and decreased therapeutic efficacy in the treatment of Behçet's disease with infliximab. Graefes Arch Clin Exp Ophthalmol 250: 1081-1087, 2012.
  16. Iwata D, Kitaichi N, Ebihara A, Iwabuchi K, Yoshida K, Namba K, Ozaki M, Ohno S, Umezawa K, Yamashita K, Todo S, Ishida S, and Onoé K : Nuclear factor-κB inhibitor, dehydroxy methyl epoxyquinomicin, ameliorates experimental autoimmune uveoretinitis in mice. Invest Ophthalmol Vis Sci 51: 2077-2084, 2010.
  17. Iwata D, Kitamura M, Kitaichi N, Saito Y, Kon S, Namba K, Morimoto J, Ebihara A, Kitamei H, Yoshida K, Ohno S, Uede T, Ishida S, Onoé K, and Iwabuchi K : Prevention of Experimental Autoimmune Uveoretinitis by Blockade of Osteopontin with Small Interfering RNA. Exp Eye Res 90 :41-48, 2010.
  18. Kitaichi N, Miyazaki A, Stanford MR, Iwata D, Chams H, Ohno S.: Low prevalence of juvenile-onset Behcet's diease with uveitis in East/South Asian people. Br J Ophthalmol 93:1428-1430, 2009.
  19. Miyazaki Y, Iwabuchi K, Iwata D, Miyazaki A, Kon Y, Niino M, Kikuchi S, Yanagawa Y, Kaer LV, Sasaki H, Onoé K.Effect of high fat diet on NKT cell function and NKT cell-mediated regulation of Th1 responses. Scand J immunol 67:230-237, 2008.
  20. Miyazaki A, Kitaichi N, Ohgami K, Iwata D, Jin XH, Iwabuchi K, Morohashi T, Ohno S, Onoe K:Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats. Graefes Arch Clin Exp Ophthalmol 246:747-757, 2008.
  21. Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H.:Ocular features of Behcet's disease: an international collaborative study. Br J Ophthalmol 91: 1579-1582, 2007.












Copyright(C)2009 Department of Ophthalmology, Hokkaido University School of Medicine.All Rights Reserved.